Literature DB >> 27643505

Challenges in Targeting a Basic Helix-Loop-Helix Transcription Factor with Hydrocarbon-Stapled Peptides.

Amanda L Edwards1, Dimphna H Meijer2, Rachel M Guerra1, Remco J Molenaar2, John A Alberta2, Federico Bernal1, Gregory H Bird1, Charles D Stiles2, Loren D Walensky1.   

Abstract

Basic helix-loop-helix (bHLH) transcription factors play critical roles in organism development and disease by regulating cell proliferation and differentiation. Transcriptional activity, whether by bHLH homo- or heterodimerization, is dependent on protein-protein and protein-DNA interactions mediated by α-helices. Thus, α-helical decoys have been proposed as potential targeted therapies for pathologic bHLH transcription. Here, we developed a library of stabilized α-helices of OLIG2 (SAH-OLIG2) to test the capacity of hydrocarbon-stapled peptides to disrupt OLIG2 homodimerization, which drives the development and chemoresistance of glioblastoma multiforme, one of the deadliest forms of human brain cancer. Although stapling successfully reinforced the α-helical structure of bHLH constructs of varying length, sequence-specific dissociation of OLIG2 dimers from DNA was not achieved. Re-evaluation of the binding determinants for OLIG2 self-association and stability revealed an unanticipated role of the C-terminal domain. These data highlight potential pitfalls in peptide-based targeting of bHLH transcription factors given the liabilities of their positively charged amino acid sequences and multifactorial binding determinants.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27643505      PMCID: PMC5534327          DOI: 10.1021/acschembio.6b00465

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  40 in total

1.  Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3.

Authors:  H Takebayashi; S Yoshida; M Sugimori; H Kosako; R Kominami; M Nakafuku; Y Nabeshima
Journal:  Mech Dev       Date:  2000-12       Impact factor: 1.882

2.  Chemical synthesis of hydrocarbon-stapled peptides for protein interaction research and therapeutic targeting.

Authors:  Gregory H Bird; W Christian Crannell; Loren D Walensky
Journal:  Curr Protoc Chem Biol       Date:  2011-09-01

3.  Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices.

Authors:  Elizaveta S Leshchiner; Andrey Parkhitko; Gregory H Bird; James Luccarelli; Joseph A Bellairs; Silvia Escudero; Kwadwo Opoku-Nsiah; Marina Godes; Norbert Perrimon; Loren D Walensky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

4.  Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system.

Authors:  Q R Lu; D Yuk; J A Alberta; Z Zhu; I Pawlitzky; J Chan; A P McMahon; C D Stiles; D H Rowitch
Journal:  Neuron       Date:  2000-02       Impact factor: 17.173

5.  Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.

Authors:  Keith L Ligon; Emmanuelle Huillard; Shwetal Mehta; Santosh Kesari; Hongye Liu; John A Alberta; Robert M Bachoo; Michael Kane; David N Louis; Ronald A Depinho; David J Anderson; Charles D Stiles; David H Rowitch
Journal:  Neuron       Date:  2007-02-15       Impact factor: 17.173

6.  The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma.

Authors:  Shwetal Mehta; Emmanuelle Huillard; Santosh Kesari; Cecile L Maire; Diane Golebiowski; Emily P Harrington; John A Alberta; Michael F Kane; Matthew Theisen; Keith L Ligon; David H Rowitch; Charles D Stiles
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

7.  The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.

Authors:  Keith L Ligon; John A Alberta; Alvin T Kho; Jennifer Weiss; Mary R Kwaan; Catherine L Nutt; David N Louis; Charles D Stiles; David H Rowitch
Journal:  J Neuropathol Exp Neurol       Date:  2004-05       Impact factor: 3.685

8.  Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.

Authors:  Yong S Chang; Bradford Graves; Vincent Guerlavais; Christian Tovar; Kathryn Packman; Kwong-Him To; Karen A Olson; Kamala Kesavan; Pranoti Gangurde; Aditi Mukherjee; Theresa Baker; Krzysztof Darlak; Carl Elkin; Zoran Filipovic; Farooq Z Qureshi; Hongliang Cai; Pamela Berry; Eric Feyfant; Xiangguo E Shi; James Horstick; D Allen Annis; Anthony M Manning; Nader Fotouhi; Huw Nash; Lyubomir T Vassilev; Tomi K Sawyer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-14       Impact factor: 11.205

9.  Phosphorylation regulates OLIG2 cofactor choice and the motor neuron-oligodendrocyte fate switch.

Authors:  Huiliang Li; Joana Paes de Faria; Paul Andrew; Justyna Nitarska; William D Richardson
Journal:  Neuron       Date:  2011-03-10       Impact factor: 17.173

10.  Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma.

Authors:  Igor F Tsigelny; Rajesh Mukthavaram; Valentina L Kouznetsova; Ying Chao; Ivan Babic; Elmar Nurmemmedov; Sandra Pastorino; Pengfei Jiang; David Calligaris; Nathalie Agar; Miriam Scadeng; Sandeep C Pingle; Wolfgang Wrasidlo; Milan T Makale; Santosh Kesari
Journal:  Oncotarget       Date:  2017-04-04
View more
  7 in total

1.  Inhibition of Bacterial Gene Transcription with an RpoN-Based Stapled Peptide.

Authors:  Sterling R Payne; Daniel I Pau; Amanda L Whiting; Ye Joon Kim; Blaze M Pharoah; Christina Moi; Christopher N Boddy; Federico Bernal
Journal:  Cell Chem Biol       Date:  2018-06-07       Impact factor: 8.116

2.  A Cell-Permeable Stapled Peptide Inhibitor of the Estrogen Receptor/Coactivator Interaction.

Authors:  Thomas E Speltz; Jeanne M Danes; Joshua D Stender; Jonna Frasor; Terry W Moore
Journal:  ACS Chem Biol       Date:  2018-01-24       Impact factor: 5.100

3.  Editorial on "Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer".

Authors:  Dan J Raz
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

4.  The Novel Transcriptional Regulator LmbU Promotes Lincomycin Biosynthesis through Regulating Expression of Its Target Genes in Streptomyces lincolnensis.

Authors:  Bingbing Hou; Yanwei Lin; Haizhen Wu; Meijin Guo; Hrvoje Petkovic; Liyuan Tao; Xiaoyu Zhu; Jiang Ye; Huizhan Zhang
Journal:  J Bacteriol       Date:  2017-12-20       Impact factor: 3.490

5.  Inhibition of FOXP3 by stapled alpha-helical peptides dampens regulatory T cell function.

Authors:  Katrina M Hawley; Rachel J Eclov; Mathew R Schnorenberg; Yu Tian; Rhea N Shah; Anika T Thomas-Toth; Marie Fefferman; Gregory H Bird; Loren D Walensky; Matthew V Tirrell; James L LaBelle
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-13       Impact factor: 12.779

6.  Constrained Peptides with Fine-Tuned Flexibility Inhibit NF-Y Transcription Factor Assembly.

Authors:  Sadasivam Jeganathan; Mathias Wendt; Sebastian Kiehstaller; Diego Brancaccio; Arne Kuepper; Nicole Pospiech; Alfonso Carotenuto; Ettore Novellino; Sven Hennig; Tom N Grossmann
Journal:  Angew Chem Int Ed Engl       Date:  2019-10-17       Impact factor: 15.336

7.  A strategy for designing allosteric modulators of transcription factor dimerization.

Authors:  Sho Oasa; Vladana Vukojević; Rudolf Rigler; Igor F Tsigelny; Jean-Pierre Changeux; Lars Terenius
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-17       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.